Biomarkers for Alzheimer's disease in sMRI?

  • Thread starter Kunal Aggarwal
  • Start date
  • Tags
    Disease Mri
In summary, Gray matter, white matter and CSF are good biomarkers for Alzheimer's disease, however amyloid plaque cannot be detected with structural MRI. There is no clear relation between changes in GM, WM and CSF for Alzheimer's disease.
  • #1
Kunal Aggarwal
12
2
I have been looking for biomarkers for Alzheimer's disease which can be detected in structural MRI. I have gone through some papers and found that Gray matter, white matter and CSF are good biomarkers. But is there any other except?
 
Biology news on Phys.org
  • #2
Gray matter, white matter and CSF are the main components of the brain and probably encompass most of the structures of the brain that you could examine by structural MRI.
 
  • Like
Likes BillTre and Kunal Aggarwal
  • #3
I thought that Amyloid Plaque was thought to be relevant.

Cheers
 
  • #4
Amyloid plaque is certainly a biomarker for Alzheimer's, but can it be detected with structural MRI?
 
  • Like
Likes Kunal Aggarwal
  • #5
Ygggdrasil said:
Amyloid plaque is certainly a biomarker for Alzheimer's, but can it be detected with structural MRI?
No, amyloid plaques cannot be detected in structural MRI.
 
  • #6
Ygggdrasil said:
Gray matter, white matter and CSF are the main components of the brain and probably encompass most of the structures of the brain that you could examine by structural MRI.
That's good. But is there any relation between GM, WM and CSF changes for alzheimer's. Like after processing the MRI images and extracting these features from them, is there any kind of relation among these which can collectively be used to say that "yes this image is having alzheimer's".
Taking it the other way, what value of GM, WM and CSF can we take as a reference for deciding the alzheimer's from MRI image.
 
  • #7
You are getting into clinical diagnosis. First off, there is no magic bullet to diagnose Alzheimers and some related diseases, it is largely a matter of ruling out other problems. The absolutely definitive diagnosis is an autopsy.
Alzheimer's dementia results from the progressive loss (degeneration) of brain cells. This degeneration may show up in a variety of ways in brain scans.

However, these scans alone aren't enough to make a diagnosis.
From: https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/in-depth/alzheimers/art-20048075

Which is what @Ygggdrasil is trying to tell you.

PLEASE read the whole article. It explains the complexity of the diagnosis. Brain scans can sometimes be helpful - they are just not always absolutely definitive.
 
  • #8
Yes, there is no definitive way of making the diagnosis, its more like building a case, there are certain typical features of the persons history and difficulties that mean the starting point is in a good history and then some specialist cognitive testing, Alzheimer's is associated with specific patterns of cognitive difficulties but it may also cause some of the other problems with similar symptoms, so its not straight forward, depression for example is commonly present . Then because some of the symptoms can be caused by other problems a number of tests are carried out to exclude these other causes, many can be identified in simple blood tests. Various scans can be used to exclude some possible causes that can be directly imaged like vascular changes or strokes but in reality they don't add much and the cost can only be justified if the diagnosis is still unclear. Any changes that are identified are often age related and present in those without signs of dementia and many of the changes are only seen at the microscopic level. They do remain an important tool in research. Examination of the CSF is rarely used, its invasive and hard to justify though it may indicate the presence of inflammatory proteins, how significant these may be is debatable.
As Alzheimer's tends to run a lengthy course and is essentially untreatable the diagnosis will become clearer over time, the important thing is to identify and treat anything else that might be causing these symptoms or that might add to the persons problems.
 
  • Like
Likes BillTre

1. What are biomarkers for Alzheimer's disease in sMRI?

Biomarkers for Alzheimer's disease in sMRI refer to specific measurable characteristics in brain images that can indicate the presence or progression of the disease. These biomarkers can include changes in brain volume, cortical thickness, and the presence of amyloid plaques.

2. How are biomarkers for Alzheimer's disease identified in sMRI?

Biomarkers for Alzheimer's disease are identified in sMRI through a combination of imaging techniques and analysis methods. These can include structural MRI scans, diffusion tensor imaging, and amyloid PET scans. Advanced algorithms and machine learning techniques are then used to analyze the data and identify potential biomarkers.

3. What is the significance of biomarkers for Alzheimer's disease in sMRI?

Biomarkers for Alzheimer's disease in sMRI have significant implications for early detection, diagnosis, and treatment of the disease. By identifying specific changes in brain structure and function, they can help healthcare professionals make more accurate diagnoses and develop personalized treatment plans for patients.

4. Are biomarkers for Alzheimer's disease in sMRI reliable?

While biomarkers for Alzheimer's disease in sMRI have shown promising results, they are not 100% reliable. Some biomarkers may be more specific to the disease than others, and factors such as age, gender, and genetic predisposition can also affect their accuracy. Further research and validation are still needed to improve the reliability of these biomarkers.

5. Can biomarkers for Alzheimer's disease in sMRI predict the progression of the disease?

While biomarkers for Alzheimer's disease in sMRI can indicate the presence or severity of the disease, they cannot definitively predict the progression of the disease. Some biomarkers may show changes over time, but it is not yet possible to accurately predict how quickly the disease will progress in an individual patient. Ongoing research is focused on identifying more reliable biomarkers and developing predictive models for Alzheimer's disease.

Similar threads

Replies
1
Views
2K
  • Biology and Medical
Replies
4
Views
1K
  • Biology and Medical
Replies
13
Views
941
Replies
20
Views
1K
Replies
5
Views
1K
Replies
1
Views
2K
Replies
7
Views
1K
  • Biology and Medical
Replies
5
Views
913
  • Biology and Medical
Replies
2
Views
1K
Back
Top